Implantable cardiovascular sensors and computers: Interventional heart failure strategies

Current Cardiology Reports

Volumn 14, Issue 5, 2012, Pages 611-618

  Smith, Sakima A ^a   Abraham, William T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Baroreceptors activation therapy; Cardiac contractility modulation; Cardiac resynchronization; Heart failure; Hemodynamic monitoring; Impedance monitoring; Implantable cardiovascular sensors and computers

Indexed keywords

AMBULATORY MONITORING; ARTICLE; BAROREFLEX ACTIVATION THERAPY; BIOSENSOR; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; COMPARATIVE EFFECTIVENESS; DEVICE SAFETY; ELECTROSTIMULATION THERAPY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART RATE VARIABILITY; HOSPITAL READMISSION; HUMAN; IMPEDANCE; IMPLANTABLE CARDIOVASCULAR SENSOR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTRACARDIAC ELECTRICAL IMPEDANCE; INTRATHORACIC ELECTRICAL IMPEDANCE; INVASIVE PROCEDURE; LEFT ATRIAL PRESSURE SENSOR; NON INVASIVE PROCEDURE; PULMONARY ARTERY SENSOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); RIGHT VENTRICULAR SENSOR;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CARDIOGRAPHY, IMPEDANCE; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC STIMULATION THERAPY; HEART FAILURE; HEMODYNAMICS; HUMANS; MONITORING, AMBULATORY; PROSTHESES AND IMPLANTS;

EID: 84870584979     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-012-0294-6     Document Type: Article

References (50)

1. Ross JS, Chen J, Lin Z, et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail. 2010;3:97-103.
2. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418-28.
3. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011;123:e18-e209. 2010 Dec 15.
4. Klersy C, De Silvestri A, Gabutti G, et al. A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol. 2009;54:1683-94.
5. Chaudhry SI, Mattera JA, Curtis JP, et al. Telemonitoring in patients with heart failure. N Engl J Med. 2010;363:2301-9.
6. Koehler F, Winkler S, Schieber M, et al. Telemedical interventional monitoring in heart failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. Eur J Heart Fail. 2010;12:1354-62.
7. Zhang J, Goode KM, Cuddihy PE, Cleland JG. TEN-HMS Investigators. Predicting hospitalization due to worsening heart failure using daily weight measurement: analysis of the Trans-European Network-home-care management system (TEN-HMS) study. Eur J Heart Fail. 2009;11:420-7.
8. Abraham WT, Compton S, Haas G, et al. On behalf of the FAST Study Investigators. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail. 2011;17:51-5.
9. Chaudhry SI, Wang Y, Concato J, et al. Patterns of weight change preceding hospitalization for heart failure. Circulation. 2007;116:1549-54. (Pubitemid 47511418)
10. Smith SA, Abraham WT. Device therapy in advanced heart failure: what to put in and what to turn off: remote telemonitoring and implantable hemodynamic devices for advanced heart failure monitoring in the ambulatory setting and the evolving role of cardiac resynchronization therapy. Congest Heart Fail. 2011;17:220-6.
11. Reynolds DW, Bartelt N, Taepke R, Bennett TD. Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol. 1995;25:1176-82.
12. Adamson PB, Magalski A, Braunschweig F, et al. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003;41:565-71. (Pubitemid 36223320)
13. Bourge RC, Abraham WT, Adamson PB, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51:1073-9. (Pubitemid 351374766)
14. Ritzema J, Melton IC, Richards AM, et al. Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device. Circulation. 2007;116:2952-9. (Pubitemid 350291202)
15. Troughton RW, Ritzema J, Eigler NL, et al. Direct left atrial pressure monitoring in severe heart failure: long-term sensor performance. J Cardiovasc Transl Res. 2011;4:3-13.
16. Ritzema J, Troughton R, Melton I, et al. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation. 2010;121:1086-95.
17. Adamson PB, Abraham WT, Aaron M, et al. CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail. 2011;17:3-10.
18. Abraham WT, Adamson PB, Bourge RC, et al. The CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658-66.
19. Gómez AM, Valdivia HH, Cheng H, et al. Defective excitationcontraction coupling in experimental cardiac hypertrophy and heart failure. Science. 1997;276:800-6. (Pubitemid 27199861)
20. Dipla K, Mattiello JA, Margulies KB, et al. The sarcoplasmic reticulum and the Na+/Ca2+ exchanger both contribute to the Ca2+ transient of failing human ventricular myocytes. Circ Res. 1999;84:435-44. (Pubitemid 29120009)
21. Burkhoff D, Shemer I, Felzen B, et al. Electric currents applied during the refractory period can modulate cardiac contractility in vitro and in vivo. Heart Fail Rev. 2001;6:27-34. (Pubitemid 32328165)
22. Pappone C, Augello G, Rosanio S, et al. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study. J Cardiovasc Electrophysiol. 2004;15:418-27. (Pubitemid 38510099)
23. Butter C, Rastogi S, Minden HH, et al. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol. 2008; 51:1784-9. (Pubitemid 351608495)
24. Borggrefe MM, Lawo T, Butter C, et al. Randomized, double blind study of nonexcitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J. 2008;29:1019-28. (Pubitemid 351844673)
25. Abraham WT, Burkhoff D, Nademanee K, et al. FIX-HF-5 Investigators and Coordinators. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. Am Heart J. 2008;156: 641-8. e1.
26. Kadish A, Nademanee K, Volosin K, et al. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J. 2011;161:329-37. e1-2.
27. Abraham WT, Nademanee K, Volosin K, et al. FIX-HF-5 Investigators and coordinators. Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. J Card Fail. 2011;17:710-7.
28. Sabbah HN, Gupta RC, Imai M, et al. Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure. Circ Heart Fail. 2011;4:65-70.
29. Lovett EG, Shafer J, Kaufman CL. Chronic activation by the Rheos System: an overview of results from European and North American feasibility studies. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:4626e30.
30. Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114:345e52.
31. Georgakopoulos D, Little WC, Abraham WT, et al. Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction. J Card Fail. 2011;17:167-78.
32. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-53. (Pubitemid 34603028)
33. BristowMR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50.
34. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-49. (Pubitemid 40517094)
35. Beshai JF, Grimm RA, Nagueh SF, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007;357:2461-71. (Pubitemid 350272785)
36. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52:1834-43.
37. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-38.
38. St John Sutton M, Ghio S, Plappert T, et al. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure. Circulation. 2009;120:1858-65.
39. Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385-95.
40. Chung ES, Katra RP, Ghio S, et al. Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction 35 : a PROSPECT trial substudy. Eur J Heart Fail. 2010;12:581-7.
41. FDA Press Release September 16, 2010. Available at: http://www. Accessdata. fda. gov/cdrh-docs/pdf/p010012s230a. pdf.
42. Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005;112:841-8. (Pubitemid 41170070)
43. Ypenburg C, Bax JJ, van der Wall EE, et al. Intrathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol. 2007;99:554-7. (Pubitemid 46215562)
44. Valzania C, Eriksson MJ, Holmström N, et al. Multiple vector impedance measurements during biventricular pacing: feasibility and possible implications for hemodynamic monitoring. Pacing Clin Electrophysiol. 2009;32:1492-500.
45. Khoury DS, Naware M, Siou J, et al. Ambulatory monitoring of congestive heart failure by multiple bioelectric impedance vectors. J Am Coll Cardiol. 2009;53:1075-81.
46. Adamson PB, Smith AL, Abraham WT, et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation. 2004; 110:2389-94. (Pubitemid 39407344)
47. Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (program to access and review trending information and evaluate correlation to symptoms in patients with heart failure) study. J Am Coll Cardiol. 2010;55:1803-10.
48. Smith S, Curran J, Hund TJ, Mohler PJ. Defects in cytoskeletal signaling pathways, arrhythmia, and sudden cardiac death. Front Physiol. 2012;3:122.
49. Gudmundsson H, Curran J, Kashef F, et al. Differential regulation of EHD3 in human and mammalian heart failure. J Mol Cell Cardiol. 2012;52:1183-90.
50. Roger VL, Go AS, Lloyd-Jones DM. et al;American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-220.